Related Items

Analysts Mixed on Nabi Price

By GRANT CATTON

January 28, 2008

Nabi Biopharmaceuticals could sell for a price in the $300 million to $550 million range, analysts said last week.

The full article is available to Mergers Unleashed subscribers only

Are you an existing M&A Magazine subscriber and/or ACG member?

 Yes     No

Already a print subscriber? As a print subscriber, you are entitled to online access. Please click here to activate your account.